Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Cannabis Dependence
NCT00974376Phase 2Completed
- Sponsor
- Scripps Research
- Start
- Nov 2009
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin in cannabis use disorder (CUD), sponsored by Scripps Research. Started Nov 2009; status: completed.
02
Drugs
gabapentin
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00974376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00974376.